Medical Automation Market

Executive Summary

Medical Automation Market was valued at US $41.97 billion in 2021 and is projected to grow at 11.04% CAGR over the forecast period to reach US $78.70 billion by 2027. Medical Automation Market represented US $7.93 billion opportunity over 2019-2021 and estimated to create US $36.73 billion opportunity in 2027 over 2021.

Medical Automation from Consainsights analyses the Medical Automation Market in the Life Sciences industry over the forecast period to 2027.

Medical Automation research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Medical Automation segmentation includes End User, Region and Geography.

Based on the End User, the Medical Automation analysis covers Hospitals and Diagnostic Centers, Pharmacies, Research Labs & Institutes, Home/Ambulatory Care Settings & Others.

In End User segment, Hospitals and Diagnostic Centers segment has highest cagr growth of 9.76%.

Based on the Region, the Medical Automation analysis covers North America, Europe, Asia-Pacific, Rest of the World.

In Region segment, North America segment has highest cagr growth of 9.76%.

Based on the region, the Medical Automation analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

End User

Introduction

In 2021, Hospitals and Diagnostic Centers segment has the highest revenue of US $19.75 billion and is expected to grow at CAGR of 9.76% by 2027 Hospitals and Diagnostic Centers segment has highest cagr growth of 9.76%.

Hospitals and Diagnostic Centers

Hospitals and Diagnostic Centers segment was valued at US $16.01 billion in 2019 and is projected to grow at 9.76% CAGR over the forecast period to reach US $37.02 billion by 2027. Hospitals and Diagnostic Centers segment represented US $3.73 billion opportunity over 2019-2021 and estimated to create US $17.28 billion opportunity in 2027 over 2021.

Pharmacies

Pharmacies segment was valued at US $10.35 billion in 2019 and is projected to grow at 9.76% CAGR over the forecast period to reach US $23.92 billion by 2027. Pharmacies segment represented US $2.41 billion opportunity over 2019-2021 and estimated to create US $11.16 billion opportunity in 2027 over 2021.

Research Labs & Institutes

Research Labs & Institutes segment was valued at US $5.17 billion in 2019 and is projected to grow at 9.76% CAGR over the forecast period to reach US $11.95 billion by 2027. Research Labs & Institutes segment represented US $1.21 billion opportunity over 2019-2021 and estimated to create US $5.58 billion opportunity in 2027 over 2021.

Home/Ambulatory Care Settings & Others

Home/Ambulatory Care Settings & Others segment was valued at US $2.51 billion in 2019 and is projected to grow at 9.76% CAGR over the forecast period to reach US $5.80 billion by 2027. Home/Ambulatory Care Settings & Others segment represented US $0.59 billion opportunity over 2019-2021 and estimated to create US $2.71 billion opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $17.32 billion and is expected to grow at CAGR of 9.76% by 2027 North America segment has highest cagr growth of 9.76%.

North America

North America segment was valued at US $14.05 billion in 2019 and is projected to grow at 9.76% CAGR over the forecast period to reach US $32.48 billion by 2027. North America segment represented US $3.27 billion opportunity over 2019-2021 and estimated to create US $15.16 billion opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $7.80 billion in 2019 and is projected to grow at 9.76% CAGR over the forecast period to reach US $18.04 billion by 2027. Europe segment represented US $1.82 billion opportunity over 2019-2021 and estimated to create US $8.42 billion opportunity in 2027 over 2021.

Asia-Pacific

Asia-Pacific segment was valued at US $8.68 billion in 2019 and is projected to grow at 9.76% CAGR over the forecast period to reach US $20.06 billion by 2027. Asia-Pacific segment represented US $2.02 billion opportunity over 2019-2021 and estimated to create US $9.36 billion opportunity in 2027 over 2021.

Rest of the World

Rest of the World segment was valued at US $3.51 billion in 2019 and is projected to grow at 9.76% CAGR over the forecast period to reach US $8.13 billion by 2027. Rest of the World segment represented US $0.82 billion opportunity over 2019-2021 and estimated to create US $3.79 billion opportunity in 2027 over 2021.